ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP

Pharmacy PHA

S. 2295, H.R. 4384 and related legislation regarding pharmaceutical labeling changes

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); U.S. Trade Representative (USTR)

Bills named: H.R. 4384 (112th), S. 2295 (112th)

Trade (domestic/foreign) TRD

Issues related to implementation of US-Korea Free Trade Agreement Issues related to trade protection in Trans Pacific Partnership Issues related to trade liberalization between US and European Union

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR)

Taxation/Internal Revenue Code TAX

Issues related to reform of tax code and possible timing of any such reform bill (no bill number yet) H.R. 6353 - issues related to tax incentives for manufacturing

Contacted: SENATE; U.S. Trade Representative (USTR); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: H.R. 6353 (112th)

Copyright/Patent/Trademark CPT

HR 2182, S1734, and S2187 (as passed in Pub. L. No. 112-144) issues related to the development of antibiotics H.R. 6353 - issues related to providing intelletual property incentives for manufacturing H.R. 6502 - issues related to the provision on incentives for development of medicines for life-threatening illnesses

Contacted: U.S. Trade Representative (USTR); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2182 (112th), H.R. 6353 (112th), H.R. 6502 (112th)

Health Issues HCR

HR 2182, S1734, and S2187 (as passed in Pub. L. No. 112-144) issues related to the development of antibiotics H.R. 3026, S. 1882 and related legislative proposals regarding establishment/implementation of pharmaceutical pedigrees and tracking/tracing of pharmaceuticals from manufacturer to consumerHR 1483 - issues related to drug safety, supply chain, and facility inspections H.R. 2245, S.296, H.R. 3839 (Prescribing Access to Lifesaving Medications Act of 2011) and related legislative proposals regarding issues surrounding potential drug shortages, including notifications and public reporting H.R. 3668 issues related to increased penalties for counterfeiting drugs HR 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to 340B program amendments and implementation of statutory changes. HR 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to definition of essential health benefits and health insurance exchanges. HR 6160 - issues related to drug safety issues, including tamper resistent packaging HR 1513 - issues related to animal research HR 6502 - issues related to development of medicines for life-threatening illnesses HR 3497 - issues related to incentives for developing and improving diagnostic tests and related treatments HR 6272 - issues related to the expansion of clinical trial data banks and increase government reporting of same HR 6163 - issues related to incentives for increased research into pediatric treatments

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR)

Bills named: H.R. 2182 (112th), H.R. 3026 (112th), H.R. 3668 (112th), H.R. 2245 (112th), H.R. 6163 (112th), S. 1882 (112th), S. 296 (112th), H.R. 3497 (112th), H.R. 3839 (112th), H.R. 3590 (112th), H.R. 6160 (112th), H.R. 1513 (112th), H.R. 6502 (112th), H.R. 6272 (112th)

Medicare/Medicaid MMM

HR 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to Medicare and Medicaid reform, including possible changes to Part D and changes to Medicaid price reporting requirements. HR 2190, S 1206 and related legislative proposals regarding changes/scope of Medicare Part D rebates HR 5979 - issues related to proposed changes in Medicaid payments

Contacted: U.S. Trade Representative (USTR); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: H.R. 5979 (112th), H.R. 3590 (112th), H.R. 2190 (112th)

Consumer Issues/Safety/Products CSP

H.R. 3026, S. 1882 and related legislative proposals regarding establishment/implementation of pharmaceutical pedigrees and tracking/tracing of pharmaceuticals from manufacturer to consumer HR 1483 issues related to drug safety, supply chain, and facility inspectionsH.R. 2245, S.296, H.R. 3839 (Prescribing Access to Lifesaving Medications Act of 2011) and related legislative proposals regarding issues surrounding potential drug shortages, including notifications and public reporting H.R. 3668 issues related to increased penalties for counterfeiting drugs H.R. 6160 - issues related to drug safety, including tamper resistent packaging

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); U.S. Trade Representative (USTR)

Bills named: H.R. 1483 (112th), S. 1882 (112th), S. 296 (112th), H.R. 3839 (112th), H.R. 3026 (112th), H.R. 3668 (112th), H.R. 6160 (112th)